Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

Europe Map with virtual gavel and sound block and AI word. Concept of the EU recently adopted the AI Act, ushering in new restrictions on Artificial Intelligence use cases and mandating transparency | Image Credit: ©tanaonte -stock.adobe.com

Europe Tried to Ban Generative AI From Critical GMP. The Ban May Not Survive. It Does Not Matter.

ByBrian Drapeau

August 13th 2026

CPHI Milan Puts Sustainability to Work, Part 1

BySilvia Forroova

August 13th 2026

xxPen injector pre-assembly demands 160 PPM precision: LVDT/vision systems, tolerance control, and GAMP5 challenge testing ensure ISO 11608 compliance.

Engineering High-Speed Pen Injector Pre-Assembly Machine: Overcoming Dimensional Variability in Multi-Component Mechanism Integration

ByJordan Xu

August 13th 2026

Based on Manufacturing Intelligence Episode 6, Chris Cole and Richard Jaenisch discuss the risks of using AI in Pharma Development and Manufacturing.

Q&A: AI Coding Tools Carry the Real Risk

ByRichard Jaenisch,Christopher Cole,Zachary Zubulake

August 12th 2026

Sentynl Therapeutics and Mereo BioPharma Group have entered a collaboration to release a new treatment for alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD)

Alvelestat Deal Signals Early Manufacturing Push for AATD-LD

ByZachary Zubulake

August 12th 2026

E-Procurement  Reverse Auctions and the Supplier's Perspective

Articles in this issue

Related Content

Europe Tried to Ban Generative AI From Critical GMP. The Ban May Not Survive. It Does Not Matter.

CPHI Milan Puts Sustainability to Work, Part 1

Engineering High-Speed Pen Injector Pre-Assembly Machine: Overcoming Dimensional Variability in Multi-Component Mechanism Integration

Q&A: AI Coding Tools Carry the Real Risk

Alvelestat Deal Signals Early Manufacturing Push for AATD-LD

Trending on Pharmaceutical Technology

Pharma's AI ROI Problem Isn't a Tech Problem but a Qualification Problem

Danish Biotechs Attracting Investor Attention

Q&A: AI Coding Tools Carry the Real Risk

Inside Halo’s New Fill-Finish Platform

Alvelestat Deal Signals Early Manufacturing Push for AATD-LD

E-Procurement &#151; Reverse Auctions and the Supplier's Perspective

Articles in this issue

Related Content

Europe Tried to Ban Generative AI From Critical GMP. The Ban May Not Survive. It Does Not Matter.

CPHI Milan Puts Sustainability to Work, Part 1

Engineering High-Speed Pen Injector Pre-Assembly Machine: Overcoming Dimensional Variability in Multi-Component Mechanism Integration

Q&A: AI Coding Tools Carry the Real Risk

Alvelestat Deal Signals Early Manufacturing Push for AATD-LD

Trending on Pharmaceutical Technology

Pharma's AI ROI Problem Isn't a Tech Problem but a Qualification Problem

Danish Biotechs Attracting Investor Attention

Q&A: AI Coding Tools Carry the Real Risk

Inside Halo’s New Fill-Finish Platform

Alvelestat Deal Signals Early Manufacturing Push for AATD-LD

E-Procurement Reverse Auctions and the Supplier's Perspective